Knut A. Jaeggi

Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound

Jonathan R. Green, Klaus Müller, Knut A. Jaeggi · Journal of Bone and Mineral Research · 1994 · 420 citations

Bone Resorption, Cgp 42'446, Chemistry +19

Renal Tolerability Profile of Novel, Potent Bisphosphonates in Two Short‐Term Rat Models

Jonathan R. Green, Yves Seltenmeyer, Knut A. Jaeggi et al. · Pharmacology & Toxicology · 1997 · 86 citations · Full text

Cgp 42446, Bone Resorption, Renal Inflammation +21

Synthesis and Evaluation of (<i>S</i>)-4-(3-(2‘-[¹¹C]Isopropylamino)-2-hydroxypropoxy)-2<i>H</i>-benzimidazol-2-one ((<i>S</i>)-[¹¹C]CGP 12388) and (<i>S</i>)-4-(3-((1‘-[¹⁸F]Fluoroisopropyl)amino)-2-hydroxypropoxy)-2<i>H</i>-benzimidazol-2-one ((<i>S</i>)-[¹⁸F]Fluoro-CGP 12388) for Visualization of β-Adrenoceptors with Positron Emission Tomography

Philip H. Elsinga, Aren van Waarde, Knut A. Jaeggi et al. · Journal of Medicinal Chemistry · 1997 · 75 citations

Asymmetric synthesis of a precursor for the automated radiosynthesis of as a preferred radioligand for β-adrenergic receptors

Frank Brady, Sajinder K. Luthra, Henri-J. Tochon-Danguy et al. · International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes · 1991 · 58 citations

Preferred Radioligand, Enantioselective Synthesis, Biochemistry +7

Synthesis and Properties of Fluorescent .beta.-Adrenoceptor Ligands

H. Heithier, Dieter Hallmann, Fritz Boege et al. · Biochemistry · 1994 · 45 citations